Yibai Pharmaceutical posts first-half net loss of about 80.34 million yuan

北京商报··CN·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Yibai Pharmaceutical released its 2026 semi-annual report, showing a net loss attributable to shareholders of about 80.34 million yuan in the first half, compared with a loss of about 19.9 million yuan in the same period last year. The company achieved operating revenue of about 689 million yuan in the first half, down 30.58 percent year on year. Yibai Pharmaceutical said the loss was mainly due to a decline in sales of major products, while costs and expenses still exceeded revenue.

Impact on assets 1

Others▼ · 1 stocks
© 2026 MarketIVNews